Servicer Evaluation Report On SBI Mortgage Released Dec 12

  • ID: 2359421
  • December 2012
  • Standard & Poors
1 of 3

TOKYO (Standard & Poor's) Dec. 21, 2012--Standard & Poor's Ratings Services today said that it has released a Japanese-language servicer evaluation report on SBI Mortgage Co. Ltd. as a residential loan primary servicer. On Dec. 3, 2012, Standard & Poor's affirmed its ABOVE AVERAGE servicer evaluation ranking on SBI Mortgage as a residential loan primary servicer. The outlook on the ranking is stable. In the report, we provide our rationale for the company's ranking on SBI Mortgage in the above category, as well as an in-depth analysis of the company's servicing business and organization. Standard & Poor's bases its servicer evaluations on an objective and comprehensive assessment of a servicer's operational capabilities for servicing various types of receivables and obligatory...

Companies mentioned in this report are:
- SBI Mortgage Co. Ltd.

Action: General Comment

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- SBI Mortgage Co. Ltd.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.